Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Transplant Genomics Inc.
DescriptionBlood-based laboratory-developed test (LDT) that measures the expression of over 100 genes to help determine kidney transplant status
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationRenal, Diagnostic
Indication DetailsDistinguish between clinical acute rejection and acute dysfunction without rejection; Routine surveillance of kidney transplant status
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today